ETFsBloomberg MSCI ESG Euro Corporate Select Index
Amundi

Amundi EUR Corporate Bond ESG UCITS ETF Acc

ECRP LSEAccumulatingPhysical, full replicationLuxembourgNot PEA-eligible
Last close · EUR
53.69EUR
+0.12% · +€0.06
Published closes: 29 Oct 2026 - 30 Oct 2026
30 Oct 2026, close
ECRPBase
Fund charges
0.14%Total expense ratio (TER)
Fund size
€6.2bnall share classes
Return 1Y
-0.9%
Sharpe 3Y
0.26
Volatility 1Y
3.2%annualised
Holdings
3,108Fund holdings

Performance

Compare
  • ECRP-0.9%
  • Price, EUR

Returns

Returns1M3M6MYTD1Y3Y5Y
ECRP+0.7%-0.8%-0.2%-0.7%-0.9%+12.4%-0.6%
MSCI World+0.4%+4.9%+10.8%+16.3%+15.9%+75.5%+71.2%
Gap to MSCI World+0.2%-5.7%-11.0%-17.0%-16.7%-63.1%-71.8%

Risk and return

Sharpe ratio · 3Y
0.26
Below MSCI World · 1.24
Return p.a.
+3.7%
Volatility
3.6%
Max loss
-3.1%Sept 2026

Sharpe vs indices

MSCI World
1.24
S&P 500
1.21
STOXX Europe 600
1.04
MSCI Emerging Markets IMI
0.93
CAC 40
0.37
ECRP
0.26
Method

Weekly EUR returns from adjusted closes. Sharpe is the annualised excess return over the euro overnight rate (Xtrackers II EUR Overnight Rate Swap UCITS ETF 1C) divided by its volatility. Max loss uses daily closes.

Top holdings

Top 10
1.0%
Holdings
3,108
As of
Fund holdings
  1. 1JPMORGAN CHAS VAR Mar30 EMTNXS24612346220.11%
  2. 2AMAZON.COM IN 3.7% Mar35XS33051695030.11%
  3. 3BANCO SANTAND VAR Apr29XS29087355040.10%
  4. 4MORGAN STANLE VAR Mar29XS25950285360.10%
  5. 5VERIZON COMM VAR Aug56XS33051440010.10%
  6. 6AMAZON.COM IN 3.35% Mar32XS33051691720.10%
  7. 7GOLDMAN SACHS VAR Aug33 EMTNXS32994722020.10%
  8. 8AMAZON.COM IN 4.05% Mar39XS33051697680.10%
  9. 9AXA SA VAR May49 EMTNXS17996116420.10%
  10. 10AMAZON.COM IN 3.1% Mar30XS33051687940.10%

Countries

Classified 100.0%
Largest
22.9%United States
Top 3
52.9%
Effective number
8.31 / HHI

Market cap

Weight vs holdings

1.0%of the fund sits in the top 10 holdings
  • Holdings 1-10
  • Holdings 11-50
  • Holdings 51-200
  • Holdings 201+

Size split

Not published

Compare ETFs in Copio.

ETF comparison in the Copio app, showing costs and returns with illustrative data.

Factual research, without a suitability score or investment recommendation. Past relationships can change.